Surgery for triple-negative breast cancer- does the type of anaesthesia have an influence on oxidative stress, inflammation, molecular regulators, and outcomes of disease?

J BUON. 2018 Mar-Apr;23(2):290-295.

Abstract

Breast cancer is the most frequently diagnosed cancer in females. Triple negative breast cancer (TNBC) is a molecular subtype of breast cancer which has a high mortality rate because of aggressive proliferation, quick occurrence of metastasis, and lack of effective treatment. New data show evidence that the type of anaesthesia can affect breast cancer recurrence and long-term outcome. Because TNBC lacks targets for modern specific therapy, a perioperative period could be the field of investigations for the long-term outcomes in TNBC influence. We reviewed the literature on research focusing on the influence of anaesthetics to oxidative stress, inflammation, molecular regulators, and TNBC oncological outcomes.

Publication types

  • Review

MeSH terms

  • Anesthesia / adverse effects*
  • Biomarkers, Tumor / genetics
  • Female
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Inflammation / genetics
  • Inflammation / pathology
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local / chemically induced
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / genetics
  • Oxidative Stress / drug effects
  • Oxidative Stress / genetics
  • Perioperative Period
  • Propofol / adverse effects
  • Propofol / therapeutic use
  • Sevoflurane / adverse effects
  • Sevoflurane / therapeutic use
  • Treatment Outcome
  • Triple Negative Breast Neoplasms / classification
  • Triple Negative Breast Neoplasms / drug therapy
  • Triple Negative Breast Neoplasms / genetics
  • Triple Negative Breast Neoplasms / surgery*

Substances

  • Biomarkers, Tumor
  • Sevoflurane
  • Propofol